← Back to Catalog
Clinician access
CJC-1295 / Ipamorelin
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Blend
Blends
CJC-1295 / Ipamorelin
Formulated to stimulate natural growth hormone release over 8-12 week cycles. Administered on an empty stomach to optimize GH pulses for body composition and recovery.
- Delivery
- Subcutaneous Injection
- Starting Dose
- 100mcg CJC + 100mcg Ipa per dose (or 100mcg/50mcg depending on blend)
- Titration
- 1–3x daily (Morning / Pre-Workout / Before Bed)
- Maintenance Range
- Cycle 8–12 weeks on, then 2–4 weeks off
- Sourcing
- Compounded Blend
Quantity
Continue Browsing1
More in Blends
Wolverine (BPC-157 + TB-500)
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Wolverine (BPC-157 + TB-500)
Subcutaneous or Intramuscular Injection
Glow (BPC-157 + TB-500 + GHK-Cu)
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Glow (BPC-157 + TB-500 + GHK-Cu)
Subcutaneous or Intradermal Injection
KLOW (BPC-157 + TB-500 + GHK-Cu + KPV)
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
KLOW (BPC-157 + TB-500 + GHK-Cu + KPV)
Subcutaneous, Intradermal, or Topical Use
Sign in to view full clinical details
Reconstitution, contraindications, clinic pricing, patient handouts, monitoring cadence, and drug interactions are available to verified clinicians.